Mineralys Therapeutics (MLYS) Prepaid Assets (2022 - 2026)

Mineralys Therapeutics' (MLYS) quarterly Prepaid Assets came in at $6.4 million in Q1 2026, down 44.16% year-on-year from $11.5 million in Q1 2025, and up 34.92% quarter-over-quarter from $4.8 million in Q4 2025.

Mineralys Therapeutics (MLYS) Prepaid Assets (2022 - 2026) Analysis & Trends

Mineralys Therapeutics has disclosed Prepaid Assets across 5 years of filings, most recently posting $6.4 million for Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $6.4 million, down 44.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 44.16% YoY), and the FY2025 annual result was $4.8 million, down 33.68% from the prior year.
  • Prepaid Assets came in at $6.4 million for Q1 2026 at Mineralys Therapeutics, up from $4.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $12.5 million in Q4 2023 to a low of $2.7 million in Q4 2022.
  • The 5-year median for Prepaid Assets is $7.0 million (2024), against an average of $7.5 million.
  • Across the five-year window, Prepaid Assets jumped 364.12% in 2023 and slumped 64.45% in 2024, its largest moves.
  • Mineralys Therapeutics' Prepaid Assets stood at $2.7 million in 2022, then surged by 364.12% to $12.5 million in 2023, then tumbled by 42.85% to $7.2 million in 2024, then sank by 33.68% to $4.8 million in 2025, then jumped by 34.92% to $6.4 million in 2026.
  • The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $4.8 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Mineralys Therapeutics 1.95 Bn 1.95 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.41 Mn
Dec 31, 2025 4.75 Mn
Sep 30, 2025 6.17 Mn
Jun 30, 2025 10.35 Mn
Mar 31, 2025 11.48 Mn
Dec 31, 2024 7.16 Mn
Sep 30, 2024 4.13 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 8.25 Mn
Dec 31, 2023 12.54 Mn
Sep 30, 2023 11.61 Mn
Jun 30, 2023 8.39 Mn
Mar 31, 2023 4.64 Mn
Dec 31, 2022 2.70 Mn